Heterosexual HIV transmission. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Heterosexual HIV transmission.

Transfus Med Rev. 1989 Jan;3(1 Suppl 1):13-6. Unique Identifier : AIDSLINE MED/92223666
Landesman S; Infectious Disease Division, SUNY Health Science Center, Brooklyn; 11203.

Abstract: Heterosexual transmission of human immunodeficiency virus (HIV) in New York City is principally a phenomenon of the urban inner city, where a large number of infected current or former drug addicts live in close social and sexual contact with inner-city women. These women are at high risk for sexual acquisition of HIV. Evidence of heterosexual transmission is already apparent in the high levels of infection in STD (sexually transmitted disease) clinics and has been noted in a New York State Department of Health study showing that 1 of every 61 women who gave birth in New York City was infected. This problem will increase and will be associated with the derivative problems of pediatric acquired immunodeficiency syndrome (AIDS). Intense targeted counseling, education, and voluntary testing of inner-city populations, combined with additional drug treatment resources, are essential if the rate of heterosexual transmission is to be decreased.
Keywords: Female Human HIV Infections/EPIDEMIOLOGY/PREVENTION & CONTROL/*TRANSMISSION Male Mothers Risk Factors *Sex Behavior Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLEKWDfemalehumanhivinfections/epidemiology/prevention&control/KWDtransmissionmalemothersriskfactorsKWDsexbehaviorsupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDjournalarticle
920730
M9271093

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .